Who owns REVANCE THERAPEUTICS INC?
- CUSIP Number: 761330ab5
Tip: Access positions for across all investors
Analyze quarterly positions in Revance Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revance Therapeutics stock
Who bought or sold REVANCE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS O'Connor | 40M | $30M | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 38M | $28M | 0% | Mar 2024 |
|
| Graham Capital Management | 32M | $24M | 0% | Mar 2024 |
|
| Franklin Resources | 30M | $22M | -31% | Mar 2024 |
|
| Aviva | 21M | $15M | -7% | Mar 2024 |
|
| Highbridge Capital Management | 16M | $11B | -21% | Mar 2024 |
|
| Silverback Asset Management | 15M | $11M | 200% | Mar 2024 |
|
| Nuveen Asset Management | 10M | $7.3M | -29% | Mar 2024 |
|
| SSI Investment Management | 7.8M | $6.0M | 14% | Dec 2023 |
|
| Calamos Advisors | 4.0M | $2.9M | 0% | Mar 2024 |
|
| Amundi | 3.4M | $2.4M | 0% | Mar 2024 |
|
| Sonora Investment Management Group | 3.0M | $2.2M | -4% | Mar 2024 |
|
| BlackRock | 2.5M | $1.8M | 25% | Mar 2024 |
|
| Agf Management | 2.3M | $1.7M | 100% | Mar 2024 |
|
| Credit Suisse | 2.0M | $1.8M | 0% | Mar 2024 |
|
| PenderFund Capital Management | 2.0M | $2.0M | 100% | Mar 2024 |
|
| Morgan Stanley | 1.4M | $1.0M | -54% | Mar 2024 |
|
| DCF Advisers | 600k | $426k | 100% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 491k | $356k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 250k | $182k | 0% | Mar 2024 |
|
| First Hawaiian Bank | 190k | $138k | 73% | Mar 2024 |
|
| American Century Companies | 117k | $86k | 67% | Mar 2024 |
|
| Context Capital Management | 44k | $33M | -100% | Mar 2024 |
|
| Barclays | 36k | $26k | 89% | Mar 2024 |
|
Who sold out of Revance Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 9.0M | $7.2B |
| CSS | Dec 2023 | 1.7M | $1.3M |
| Citigroup | Dec 2023 | 500k | $380k |